QA: Arbutus Biopharma Corp in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001447028_2025_Arbutus_Biopharma_Corp.pdf

Logs

Graph

Absolute values for 0001447028, Arbutus Biopharma Corp

  xvar xval
0 AssetsCurrent 127,316,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,309,000
3 remainder_Assets 1,082,000
4 LiabilitiesCurrent 15,618,000
5 LiabilitiesNoncurrent 806,000
6 remainder_Liabilities 17,917,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 22,105,909
9 ResearchAndDevelopmentExpense 30,687,156
10 remainder_Expenses 4,414,722
11 remainder_Revenues 9,024,103
12 remainder_NetIncome 6,151,617
13 remainder_ComprehensiveNetIncome 812,692
  yvar yval
0 Assets 131,707,000
1 Liabilities 34,341,000
2 Expenses 57,207,787
3 Revenues 9,024,103
4 StockholdersEquity 97,366,000
5 NetIncome -42,032,067
6 ComprehensiveNetIncome -41,625,721
7 BaseVar 119,622,100
8 EconomicCapitalRatiobeforeLimitedLiability 2.06
9 EconomicCapitalRatio 3.06

Edgar->Model Mapping

Feature Distribution

Change over Time